A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer

Cytoscape: A software Environment for integrated models of biomolecular interaction networks

Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888 · see citing works

Cancer statistics, 2016

Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003 · see citing works

ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform

Rhodes, D. R., Yu, J., Sundaram, S. K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T. R., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,615 · see citing works

Detection and localization of surgically resectable cancers with a multi-analyte blood test

Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783 · see citing works

Pancreatitis and the Risk of Pancreatic Cancer

Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R., Lankisch, P. G., Andersen, J. R., DiMagno, E. P., Andrén‐Sandberg, Å., & Domellöf, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,753 · see citing works

Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases

Casero, R. A., & Marton, L. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2243 · Cited by 752 · see citing works

Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development

Mayers, J. R., Wu, C. H., Clish, C. B., Kraft, P., Torrence, M. E., Fiske, B. P., Yuan, C., Bao, Y., Townsend, M. K., Tworoger, S. S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3686 · Cited by 652 · see citing works

JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance

Wang, T., Fahrmann, J., Lee, H., Li, Y.-J., Tripathi, S. C., Yue, C., Zhang, C.-Y., Lifshitz, V., Song, J., Yuan, Y., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.001 · Cited by 580 · see citing works

Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia.

Badea, L., Herlea, V., Dima, S., Dumitraşcu, T., & Popescu, I. (2008) · PubMed · Cited by 531 · see citing works

CA 19-9: Biochemical and Clinical Aspects

Scarà, S., Bottoni, P., & Scatena, R. (2015) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-017-7215-0_15 · Cited by 351 · see citing works

New insights into pancreatic cancer-induced paraneoplastic diabetes

Sah, R. P., Nagpal, S. J. S., Mukhopadhyay, D., & Chari, S. T. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.49 · Cited by 336 · see citing works

Metabolomics in cancer biomarker discovery: Current trends and future perspectives

Armitage, E. G., & Barbas, C. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.08.041 · Cited by 330 · see citing works

Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis

Mayerle, J. V., Kalthoff, H., Reszka, R. C., Kamlage, B., Peter, E., Schniewind, B., Maldonado, S. G., Pilarsky, C. P., Heidecke, C.-D., Schatz, P., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312432 · Cited by 310 · see citing works

Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection

O'Brien, D. P., Sandanayake, N. S., Jenkinson, C., Gentry-Maharaj, A., Apostolidou, S., Fourkala, E.-O., Camuzeaux, S., Blyuss, O., Gunu, R., Dawnay, A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0365 · Cited by 200 · see citing works

Cystic precursors to invasive pancreatic cancer

Matthaei, H., Schulick, R. D., Hruban, R. H., & Maitra, A. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.2 · Cited by 193 · see citing works

Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer

Capello, M., Bantis, L. E., Scélo, G., Zhao, Y., Peng, L., Dhillon, D. S., Patel, N. J., Kundnani, D. L., Wang, H., Abbruzzese, J. L., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw266 · Cited by 145 · see citing works

Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver

Grünwald, B. T., Harant, V., Schaten, S., Frühschütz, M., Spallek, R., Höchst, B., Stutzer, K., Berchtold, S., Erkan, M., Prokopchuk, O., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.043 · Cited by 129 · see citing works

Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer

Tomaino, B., Cappello, P., Capello, M., Fredolini, C., Sperduti, I., Migliorini, P., Salacone, P., Novarino, A., Giacobino, A., Ciuffreda, L., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr100213b · Cited by 124 · see citing works

Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non–Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B

Wikoff, W. R., Hanash, S., DeFelice, B. C., Miyamoto, S., Barnett, M. J., Zhao, Y., Goodman, G. E., Feng, Z., Gandara, D. R., Fiehn, O., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.7779 · Cited by 103 · see citing works

Prediagnostic Serum Biomarkers as Early Detection Tools for Pancreatic Cancer in a Large Prospective Cohort Study

Nolen, B. M., Brand, R. E., Prosser, D., Velikokhatnaya, L., Allen, P. J., Zeh, H. J., Grizzle, W. E., Lomakin, A., & Lokshin, A. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094928 · Cited by 94 · see citing works

Autoantibody Signature in Human Ductal Pancreatic Adenocarcinoma

Tomaino, B., Cappello, P., Capello, M., Fredolini, C., Ponzetto, A., Novarino, A., Ciuffreda, L., Bertetto, O., Angelis, C. D., Gaia, E., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr070281a · Cited by 81 · see citing works

Metabonomics: A Useful Tool for the Future Surgeon

Goldsmith, P., Fenton, H. M., Morris‐Stiff, G., Ahmad, N., Fisher, J., & Prasad, R. K. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.03.003 · Cited by 73 · see citing works

Advances in Biomarker Research for Pancreatic Cancer

Bhat, K., Wang, F., Ma, Q., Li, Q., Mallik, S., Hsieh, T., & Wu, E. (2012) · Current Pharmaceutical Design · doi:10.2174/13816128112092439 · Cited by 73 · see citing works

Integrated Metabolomics and Proteomics Highlight Altered Nicotinamide- and Polyamine Pathways in Lung Adenocarcinoma

Fahrmann, J. F., Grapov, D., Wanichthanarak, K., DeFelice, B. C., Salemi, M., Rom, W. N., Gandara, D. R., Phinney, B. S., Fiehn, O., Pass, H. I., et al. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw205 · Cited by 72 · see citing works

Evaluating the utility of N1,N12-diacetylspermine and N1,N8-diacetylspermidine in urine as tumor markers for breast and colorectal cancers

Umemori, Y., Ohe, Y., Kuribayashi, K., Tsuji, N., Nishidate, T., Kameshima, H., Hirata, K., & Watanabe, N. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.018 · Cited by 62 · see citing works

Metabolomic biomarkers of pancreatic cancer: a meta-analysis study

Mehta, K. Y., Wu, H.-J., Menon, S. S., Fallah, Y., Zhong, X., Rizk, N. M., Unger, K. R., Mapstone, M. E., Fiandaca, M. S., Federoff, H. J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20324 · Cited by 61 · see citing works

Polyamine Concentrations in Pancreatic Tissue, Serum, and Urine of Patients with Pancreatic Cancer

Löser, C., Fölsch, U. R., Paprotny, C., & Creutzfeldt, W. (1990) · Pancreas · doi:10.1097/00006676-199003000-00001 · Cited by 54 · see citing works

Polyamine Transport Systems in Mammalian Cells and Tissues

Uemura, T., & Gerner, E. W. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-034-8_21 · Cited by 53 · see citing works

Surgical treatment of liver metastases from pancreatic cancer

Yamada, H., Hirano, S., Tanaka, E., Shichinohe, T., & Kondo, S. (2006) · HPB · doi:10.1080/13651820500472200 · Cited by 52 · see citing works

Toward a Better Understanding of Pancreatic Ductal Adenocarcinoma

Partensky, C. (2013) · Pancreas · doi:10.1097/mpa.0b013e318288107a · Cited by 32 · see citing works

Serum Metabolite Profiling for the Detection of Pancreatic Cancer

Akita, H., Ritchie, S. A., Takemasa, I., Eguchi, H., Pastural, É., Jin, W., Yamazaki, Y., Goodenowe, D. B., Nagano, H., Monden, M., et al. (2016) · Pancreas · doi:10.1097/mpa.0000000000000680 · Cited by 32 · see citing works

Laminin surface binding sites and metastatic potential of 3LL tumor cells, increased by indomethacin

Aliño, S. F., Unda, F. J., & Pérez‐Yarza, G. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92086-f · Cited by 14 · see citing works

Fibroblasts form a hospitable metastatic niche in the liver

Erez, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3352 · Cited by 8 · see citing works

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

McGuigan, A. J., Kelly, P. J., Turkington, R. C., Jones, C. A., Coleman, H. G., & McCain, R. S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i43.4846 · Cited by 1,933 · see citing works

Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter

Luo, G., Jin, K., Deng, S., Cheng, H., Fan, Z., Gong, Y., Qian, Y., Huang, Q., Ni, Q., Liu, C., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188409 · Cited by 446 · see citing works

Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma

Yu, S., Li, Y., Liao, Z., Wang, Z., Wang, Z., Li, Y., Qian, L., Zhao, J., Zong, H., Kang, B., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318860 · Cited by 241 · see citing works

Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection

Fahrmann, J. F., Schmidt, C. M., Mao, X., Irajizad, E., Loftus, M., Zhang, J., Patel, N., Vykoukal, J., Dennison, J. B., Long, J. P., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.11.052 · Cited by 208 · see citing works

LRG1: an emerging player in disease pathogenesis

Camilli, C., Hoeh, A. E., Rossi, G. D., Moss, S. E., & Greenwood, J. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00790-6 · Cited by 195 · see citing works

Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review

Kenner, B., Chari, S. T., Kelsen, D., Klimstra, D. S., Pandol, S. J., Rosenthal, M., Rustgi, A. K., Taylor, J. A., Yala, A., Abul-Husn, N., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001762 · Cited by 158 · see citing works

Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?

O'Neill, R. S., & Stoita, A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i26.4045 · Cited by 144 · see citing works

Blood biomarkers for differential diagnosis and early detection of pancreatic cancer

Al-Shaheri, F. N., Alhamdani, M. S. S., Bauer, A. S., Giese, N. A., Büchler, M. W., Hackert, T., & Hoheisel, J. D. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102193 · Cited by 115 · see citing works

Non-internalising antibody–drug conjugates

Ashman, N., Bargh, J. D., & Spring, D. R. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00446a · Cited by 94 · see citing works

Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer

Fahrmann, J. F., Vykoukal, J. V., Fleury, A., Tripathi, S. C., Dennison, J. B., Murage, E. N., Wang, P., Yu, C., Capello, M., Creighton, C. J., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz182 · Cited by 85 · see citing works

Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer

Fan, Z., Luo, G., Gong, Y., He, X., Qian, Y., Deng, S., Huang, Q., Yang, C., Cheng, H., Jin, K., et al. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08301-3 · Cited by 86 · see citing works

Coupled liquid biopsy and bioinformatics for pancreatic cancer early detection and precision prognostication

Hou, J., Li, X., & Xie, K. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01309-7 · Cited by 86 · see citing works

Metabolic detection and systems analyses of pancreatic ductal adenocarcinoma through machine learning, lipidomics, and multi-omics

Wang, G., Yao, H., Gong, Y., Lu, Z., Pang, R., Li, Y., Yuan, Y., Song, H., Liu, J., Jin, Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh2724 · Cited by 85 · see citing works

Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer

Vykoukal, J. V., Fahrmann, J. F., Gregg, J. R., Tang, Z., Basourakos, S. P., Irajizad, E., Park, S., Yang, G., Creighton, C. J., Fleury, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17645-z · Cited by 82 · see citing works

Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma

Buscail, É., Maulat, C., Muscari, F., Chiche, L., Cordelier, P., Dabernat, S., Alix‐Panabières, C., & Buscail, L. (2019) · Cancers · doi:10.3390/cancers11060852 · Cited by 75 · see citing works

Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinomaPreprint

Venkat, S., Tisdale, A. A., Schwarz, J. R., Alahmari, A. A., Maurer, H. C., Olive, K. P., Eng, K. H., & Feigin, M. E. (2020) · Genome Research · doi:10.1101/gr.257550.119 · Cited by 72 · see citing works

Cancer screening with multicancer detection tests: A translational science review

Rubinstein, W. S., Patriotis, C., Dickherber, A. J., Han, P. K. J., Katki, H. A., LeeVan, E. M., Pinsky, P. F., Prorok, P. C., Skarlupka, A. L., Temkin, S. M., et al. (2024) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21833 · Cited by 70 · see citing works

Research Progress on Leucine-Rich Alpha-2 Glycoprotein 1: A Review

Zou, Y., Xu, Y., Chen, X., Wu, Y., Fu, L., & Lv, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.809225 · Cited by 62 · see citing works

Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s)

Carmicheal, J., Patel, A., Dalal, V., Atri, P., Dhaliwal, A., Wittel, U. A., Malafa, M. P., Talmon, G. A., Swanson, B. J., Singh, S., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.188318 · Cited by 55 · see citing works

Clinical Trials of Systemic Chemotherapy for Resectable Pancreatic Cancer

Mavros, M. N., Moris, D., Karanicolas, P. J., Katz, M. H. G., O'Reilly, E. M., & Pawlik, T. M. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2021.0149 · Cited by 55 · see citing works

Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer

Kato, S., & Honda, K. (2020) · Cancers · doi:10.3390/cancers12071965 · Cited by 54 · see citing works

Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma

Wang, C., Wang, J., Cui, W., Liu, Y., Zhou, H., Wang, Y., Chen, X., Chen, X., & Wang, Z. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s296816 · Cited by 52 · see citing works

Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial

Zhang, X., Irajizad, E., Hoffman, K. L., Fahrmann, J. F., Li, F., Seo, Y. D., Browman, G. J., Dennison, J. B., Vykoukal, J. V., Luna, P. N., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104873 · Cited by 51 · see citing works

Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer – a comprehensive review

Reese, K.-L., Pantel, K., & Smit, D. J. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03166-w · Cited by 54 · see citing works

Pancreatic Cancer Biomarkers: Oncogenic Mutations, Tissue and Liquid Biopsies, and Radiomics—A Review

Amaral, M. J., Oliveira, R. C., Donato, P., & Tralhão, J. G. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-07904-6 · Cited by 49 · see citing works

A blood-based metabolomic signature predictive of risk for pancreatic cancer

Irajizad, E., Kenney, A., Tang, T. M., Vykoukal, J., Wu, R., Murage, E. N., Dennison, J. B., Sans, M., Long, J. P., Loftus, M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101194 · Cited by 44 · see citing works

Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review

Brezgyte, G., Shah, V. M., Jach, D., & Crnogorac‐Jurcevic, T. (2021) · Cancers · doi:10.3390/cancers13112722 · Cited by 43 · see citing works

Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study

Zhao, R., Ren, S., Li, C., Guo, K., Lu, Z., Tian, L., He, J., Zhang, K., Cao, Y., Liu, S., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.5296 · Cited by 43 · see citing works

Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma

Fahrmann, J. F., Tanaka, I., Irajizad, E., Mao, X., Dennison, J. B., Murage, E. N., Casabar, J. P., Mayo, J., Peng, Q., Çeliktaş, M., et al. (2022) · Cancers · doi:10.3390/cancers14102543 · Cited by 42 · see citing works

Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients

Peng, H., Pan, S., Yan, Y., Brand, R. E., Petersen, G. M., Chari, S. T., Lai, L. A., Eng, J. K., Brentnall, T. A., & Chen, R. (2020) · Cancers · doi:10.3390/cancers12061534 · Cited by 39 · see citing works

Understanding Necroptosis in Pancreatic Diseases

He, R., Wang, Z., Dong, S., Chen, Z., & Zhou, W. (2022) · Biomolecules · doi:10.3390/biom12060828 · Cited by 38 · see citing works

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma

Wang, P. P., Song, X., Zhao, X. K., Wei, M. X., Gao, S. G., Zhou, F. Y., Han, X., Xu, R., Wang, R., Fan, Z. M., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.790933 · Cited by 35 · see citing works

Plasma-Derived Extracellular Vesicles Convey Protein Signatures That Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas

Fahrmann, J. F., Mao, X., Irajizad, E., Katayama, H., Capello, M., Tanaka, I., Kato, T., Wistuba, I. I., Maitra, A., Ostrin, E. J., et al. (2020) · Cancers · doi:10.3390/cancers12051147 · Cited by 34 · see citing works

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics

Martín-Blázquez, A., Jiménez‐Luna, C., Díaz, C., Martínez-Galán, J., Prados, J. C., Vicente, F., Melguizo, C., Genilloud, O., del Palacio, J. P., & Caba, O. (2020) · Cancers · doi:10.3390/cancers12041002 · Cited by 34 · see citing works

The clinical application of 18F-FDG PET/CT in pancreatic cancer: a narrative review

Pu, Y., Wang, C., Zhao, S., Xie, R., Zhao, L., Li, K., Yang, C., Zhang, R., Tian, Y., Tan, L., et al. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-169 · Cited by 33 · see citing works

A multicentre clinical validation of AminoIndex Cancer Screening (AICS)

Mikami, H., Kimura, O. S., Yamamoto, H., Kikuchi, S., Nakamura, Y., Ando, T., & Yamakado, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-50304-y · Cited by 33 · see citing works

Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target

Javaid, F., Pilotti, C., Camilli, C., Kallenberg, D. M., Bahou, C., Blackburn, J. W. D., Baker, J. R., Greenwood, J., Moss, S. E., & Chudasama, V. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00104c · Cited by 33 · see citing works

A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9 alone

Haab, B. B., Qian, L., Staal, B., Jain, M., Fahrmann, J. F., Worthington, C., Prosser, D., Velokokhatnaya, L., Lopez, C., Tang, R., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217245 · Cited by 32 · see citing works

Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application

Indellicato, R., Zulueta, A., Caretti, A., & Trinchera, M. (2020) · Cancers · doi:10.3390/cancers12061509 · Cited by 32 · see citing works

A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer

Fahrmann, J. F., Irajizad, E., Kobayashi, M., Vykoukal, J., Dennison, J. B., Murage, E. N., Wu, R., Long, J. P., Do, K.-A., Celestino, J., et al. (2021) · Cancers · doi:10.3390/cancers13040913 · Cited by 32 · see citing works

Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population

Kim, J., Yuan, C., Babić, A., Bao, Y., Clish, C. B., Pollak, M., Amundadottir, L. T., Klein, A. P., Stolzenberg‐Solomon, R. Z., Pandharipande, P. V., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1389 · Cited by 29 · see citing works

Evaluating Metabolite-Based Biomarkers for Early Diagnosis of Pancreatic Cancer: A Systematic Review

Perazzoli, G., García-Valdeavero, O. M., Peña, M., Prados, J. C., Melguizo, C., & Jiménez‐Luna, C. (2023) · Metabolites · doi:10.3390/metabo13070872 · Cited by 28 · see citing works

Elucidating the role of blood metabolites on pancreatic cancer risk using two‐sample Mendelian randomization analysis

Zhong, H., Liu, S., Zhu, J., Xu, T. H., Yu, H., & Wu, L. (2023) · International Journal of Cancer · doi:10.1002/ijc.34771 · Cited by 28 · see citing works

Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration

Kane, L. E., Mellotte, G. S., Conlon, K. C., Ryan, B. M., & Maher, S. G. (2021) · Cancers · doi:10.3390/cancers13040769 · Cited by 27 · see citing works

LRG1 Suppresses Migration and Invasion of Esophageal Squamous Cell Carcinoma by Modulating Epithelial to Mesenchymal Transition

Zhang, N., Ren, Y., Wang, Y., Zhao, L., Wang, B., Ma, N., Gao, Z., & Cao, B. (2020) · Journal of Cancer · doi:10.7150/jca.36189 · Cited by 26 · see citing works

Integrated models of blood protein and metabolite enhance the diagnostic accuracy for Non-Small Cell Lung Cancer

Xu, R., Wang, J., Zhu, Q., Zou, C., Wei, Z., Wang, H., Ding, Z., Meng, M., Wei, H., Xia, S., et al. (2023) · Biomarker Research · doi:10.1186/s40364-023-00497-2 · Cited by 25 · see citing works

Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Irajizad, E., Wu, R., Vykoukal, J. V., Murage, E. N., Spencer, R., Dennison, J. B., Moulder, S. L., Ravenberg, E. E., Lim, B., Litton, J. K., et al. (2022) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2022.876100 · Cited by 24 · see citing works

Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis

Léon-Letelier, R. A., Sater, A. H. A., Chen, Y., Park, S., Wu, R., Irajizad, E., Dennison, J. B., Katayama, H., Vykoukal, J. V., Hanash, S., et al. (2023) · Cancers · doi:10.3390/cancers15030834 · Cited by 24 · see citing works

The prowess of metabolomics in cancer research: current trends, challenges and future perspectives

Taunk, K., Jajula, S., Bhavsar, P. P., Choudhari, M., Bhanuse, S. G., Tamhankar, A. S., Naiya, T., Kalita, B., & Rapole, S. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05041-w · Cited by 23 · see citing works

Screening for pancreatic cancer has the potential to save lives, but is it practical?

Mazer, B. L., Lee, J. W., Roberts, N. J., Chu, L. C. H., Lennon, A. M., Klein, A. P., Eshleman, J. R., Fishman, E. K., Canto, M. I., Goggins, M., et al. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2217354 · Cited by 23 · see citing works

A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

Jiao, L., Maity, S., Coarfa, C., Rajapakshe, K., Chen, L., Jin, F., Putluri, V., Tinker, L. F., Mo, Q., Chen, F., et al. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0201 · Cited by 23 · see citing works

The relationship of the microbiome, associated metabolites and the gut barrier with pancreatic cancer

Daniel, N., Farinella, R., Belluomini, F., Fajkić, A., Rizzato, C., Souček, P., Campa, D., & Hughes, D. J. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.03.002 · Cited by 21 · see citing works

Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer

Bararia, A., Chakraborty, P., Roy, P., Chattopadhyay, B. K., Das, A. K., Chatterjee, A., & Sikdar, N. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i15.2241 · Cited by 20 · see citing works

Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer

Léon-Letelier, R. A., Dou, R., Vykoukal, J. V., Yip-Schneider, M., Maitra, A., Irajizad, E., Wu, R., Dennison, J. B., Do, K., Zhang, J., et al. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad186 · Cited by 20 · see citing works

Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer

Iovanna, J. (2021) · Translational Oncology · doi:10.1016/j.tranon.2020.100965 · Cited by 18 · see citing works

A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression

Fahrmann, J. F., Wasylishen, A. R., Pieterman, C. R. C., Irajizad, E., Vykoukal, J. V., Murage, E. N., Wu, R., Dennison, J. B., Krishna, H., Peterson, C. B., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab554 · Cited by 18 · see citing works

A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma

Fahrmann, J. F., Saini, N. Y., Chia-Chi, C., Irajizad, E., Strati, P., Nair, R. K., Fayad, L., Ahmed, S., Lee, H. J., Iyer, S. P., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100720 · Cited by 18 · see citing works

Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN

Liu, Y., Kaur, S., Huang, Y., Fahrmann, J. F., Rinaudo, J. A., Hanash, S. M., Batra, S. K., Singhi, A. D., Brand, R. E., Maitra, A., et al. (2020) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0161 · Cited by 17 · see citing works

A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses

Irajizad, E., Han, C. Y., Celestino, J., Wu, R., Murage, E. N., Spencer, R., Dennison, J. B., Vykoukal, J. V., Long, J. P., Do, K., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1113 · Cited by 16 · see citing works

Machine learning facilitates the application of mass spectrometry-based metabolomics to clinical analysis: A review of early diagnosis of high mortality rate cancers

Ngan, H., Lam, K.-Y., Li, Z., Zhang, J., & Cai, Z. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117333 · Cited by 15 · see citing works

Potential Metabolite Markers for Pancreatic Cancer Identified by Metabolomic Analysis of Induced Cancer-Associated Fibroblasts

Miyazaki, Y., Mori, N., Akagi, Y., Oda, T., & Kida, Y. S. (2022) · Cancers · doi:10.3390/cancers14061375 · Cited by 15 · see citing works

Unraveling altered RNA metabolism in pancreatic cancer cells by liquid-chromatography coupling to ion mobility mass spectrometry

Lagies, S., Schlimpert, M., Braun, L. M., Kather, M., Plagge, J., Erbes, T., Wittel, U. A., & Kammerer, B. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-01814-1 · Cited by 14 · see citing works

Linking metabolomics to machine learning reveals the metabolic fates of the refractory industrial pollutant 1-Hexadecene

Yang, L., Xu, X., Yan, J., Wang, W., Wang, X., Xing, D., Ren, N., Lee, D.-J., & Chen, C. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.150920 · Cited by 14 · see citing works

Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients

Bourgin, M., Derosa, L., Silva, C. A. C., Goubet, A., Dubuisson, A., Danlos, F., Grajeda‐Iglesias, C., Cerbone, L., Géraud, A., Laparra, A., et al. (2021) · Aging · doi:10.18632/aging.203525 · Cited by 14 · see citing works

Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer

Guo, D., Ye, L., Wu, W., Yu, X., & Jin, K. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023045 · Cited by 13 · see citing works

Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples

Treekitkarnmongkol, W., Dai, J., Liu, S., Sankaran, D., Nguyen, T., Balasenthil, S., Hurd, M. W., Chen, M., Katayama, H., Roy‐Chowdhuri, S., et al. (2024) · Gastro Hep Advances · doi:10.1016/j.gastha.2024.08.002 · Cited by 14 · see citing works

β6-Integrin Serves as a Potential Serum Marker for Diagnosis and Prognosis of Pancreatic Adenocarcinoma

Lenggenhager, D. M., Bengs, S., Fritsch, R., Hussung, S., Busenhart, P., Endhardt, K., Töpfer, A., The, F. O., Bütikofer, S., Gubler, C., et al. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000395 · Cited by 13 · see citing works

The Prognostic Impact of Leucine-Rich α-2-Glycoprotein-1 in Cholangiocarcinoma and Its Association With the IL-6/TGF-β1 Axis

Jin, Z. H., Kobayashi, S., Gotoh, K., Takahashi, T., Eguchi, H., Naka, T., Mori, M., & Doki, Y. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.03.018 · Cited by 12 · see citing works

Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma

Kothari, A., & Flick, M. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105138 · Cited by 11 · see citing works

Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma

Supadmanaba, I. G. P., Mantini, G., Randazzo, O., Capula, M., Muller, I. B., Cascioferro, S., Diana, P., Peters, G. J., & Giovannetti, E. (2021) · Epigenetics · doi:10.1080/15592294.2021.1916697 · Cited by 10 · see citing works

Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Promoting Role

Lee, M. J., Na, K., Shin, H., Kim, C.-Y., Cho, J.-Y., Kang, C. M., Kim, S. H., Kim, H., Choi, H. J., Lee, C., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00805 · Cited by 10 · see citing works

Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma

Ali, A. H., Chianese, U., Papulino, C., Toraldo, A., Abakar, M. E. A., Passaro, E., Cennamo, R., Gaudio, N. D., Altucci, L., & Benedetti, R. (2022) · Cancers · doi:10.3390/cancers14153799 · Cited by 10 · see citing works

Statistical inference for the difference between two maximized Youden indices obtained from correlated biomarkers

Bantis, L. E., Nakas, C. T., & Reiser, B. (2021) · Biometrical Journal · doi:10.1002/bimj.202000128 · Cited by 9 · see citing works

Diagnostic yield of the plasma free amino acid index for pancreatic cancer in patients with diabetes mellitus

Mizuno, S., Isayama, H., Nakai, Y., Ishigaki, K., Saito, K., Sato, T., Takeda, T., Hakuta, R., Saito, T., Takahara, N., et al. (2019) · Pancreatology · doi:10.1016/j.pan.2019.07.002 · Cited by 9 · see citing works

Plasma Based Protein Signatures Associated with Small Cell Lung Cancer

Fahrmann, J. F., Katayama, H., Irajizad, E., Chakraborty, A. D., Kato, T., Mao, X., Park, S., Murage, E. N., Rusling, L. A., Yu, C., et al. (2021) · Cancers · doi:10.3390/cancers13163972 · Cited by 8 · see citing works

Lead time trajectory of blood-based protein biomarkers for detection of pancreatic cancer based on repeat testing

Fahrmann, J. F., Yip-Schneider, M., Vykoukal, J., Spencer, R., Dennison, J. B., Do, K.-A., Long, J. P., Maitra, A., Zhang, J., Schmidt, C. M., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217450 · Cited by 7 · see citing works

Is the Early Detection of Pancreatic Cancer Possible? It Is Good News, Bad News

Hruban, R. H. (2019) · Pancreas · doi:10.1097/mpa.0000000000001299 · Cited by 7 · see citing works

Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review

Vellan, C. J., Jayapalan, J. J., Yoong, B., Aziz, A. A., Junit, S. M., & Subramanian, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042093 · Cited by 7 · see citing works

Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance

Gregg, J. R., Newcomb, L. F., Wu, R., Dennison, J. B., Davis, J. W., Pettaway, C. A., Pisters, L. L., Ward, J. F., Chapin, B. F., Chery, L. J., et al. (2024) · Biomarker Research · doi:10.1186/s40364-024-00678-7 · Cited by 6 · see citing works

Pancreatic Cancers: A Review of Studies from Pakistan and Comparison with Global Trends

Ali, S. M., Adnan, Y., & Ali, S. M. A. (2021) · Pakistan Journal of Public Health · doi:10.32413/pjph.v11i2.741 · Cited by 6 · see citing works

iTRAQ-Based Proteomic Analysis Reveals Potential Serum Biomarkers for Pediatric Non-Hodgkin’s Lymphoma

Yu, R., Cheng, L., Yang, S., Liu, Y., & Zhu, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.848286 · Cited by 6 · see citing works

Exosome and lipid metabolism-related genes in pancreatic adenocarcinoma: a prognosis analysis

Wu, J. H., Li, Y., Nabi, G., Huang, X., Zhang, X., Wang, Y., & Huang, L. (2023) · Aging · doi:10.18632/aging.205130 · Cited by 6 · see citing works

Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alterationPreprint

Sans, M., Chen, Y., Thege, F. I., Dou, R., Min, J., Yip-Schneider, M., Zhang, J., Wu, R., Irajizad, E., Makino, Y., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.14.553002 · Cited by 6 · see citing works

Metabolomic landscape of renal cell carcinoma in von Hippel-Lindau syndrome in a Chinese cohort

Zhang, Z., Wang, Y., Yang, W., Liu, T., Wang, C., Huang, C. X., Xu, Y., Chen, X., Zhou, J., Wang, Y., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110357 · Cited by 5 · see citing works

Metabolomics for searching validated biomarkers in cancer studies: a decade in review

López-López, Á., López‐Gonzálvez, Á., & Barbas, C. (2024) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2024.2368603 · Cited by 6 · see citing works

CA19-9 as a therapeutic target in pancreatitis

Kato, S., & Honda, K. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.161 · Cited by 5 · see citing works

Extracellular vesicle biomarkers in pancreatic ductal adenocarcinoma: from bulk detection to single-extracellular vesicle profiling and endoscopic liquid biopsy

Shimamoto, N., Sumiyama, K., & Fujita, Y. (2026) · Journal of Gastroenterology · doi:10.1007/s00535-026-02350-3 · Cited by 4 · see citing works

PanMETAI - a high performance tabular foundation model for accurate pancreatic cancer diagnosis via NMR metabolomics

Wu, D., Jen, J., Fajiculay, E., Hsu, M., Chang, M., Yeh, J.-C., Sargsyan, K., Kupčinskas, J., Skiecevičienė, J., Steponaitienė, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69426-9 · Cited by 4 · see citing works

Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma

Osei‐Bordom, D., Sachdeva, G. S., & Christou, N. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.788869 · Cited by 5 · see citing works

Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyamine Metabolism as a Biomarker of Progression

Léon-Letelier, R. A., Chen, Y., Dou, R., Irajizad, E., Yip-Schneider, M., Wu, R., Ejaz, R., Rudsari, H. K., Li, Y., Spencer, R., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-2931 · Cited by 5 · see citing works

BTNL9 exerts anti-cancer effects by inhibiting CDC20 to induce G2/M arrest in pancreatic cancer

Xiao, M., Luo, Z., Yu, A.-R., Xu, K., & Zhou, W. (2025) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v17.i7.108274 · Cited by 3 · see citing works

Multiplexed Quantitation of Plasma Proteins by Targeted Mass Spectrometry for Early Diagnosis of Pancreatic Ductal Adenocarcinoma

Korobkov, D., Molodtsov, I. A., Kononikhin, A. S., Bugrova, A. E., Indeykina, M. I., Brzhozovskiy, A. G., Kanner, D. Y., Николаев, Е. Н., Vasilieva, E., & Komissarov, A. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189219 · Cited by 3 · see citing works

Machine learning-optimized metabolic biomarker panel for precision screening of early-stage pancreatic cancer in new-onset diabetes

Jiang, W., Cheng, Z., Mu, R., Sun, H., Guo, Z., Guo, Y., Wang, D., & Yang, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1684608 · Cited by 3 · see citing works

The Case for GNMT as a Biomarker and a Therapeutic Target in Pancreatic Cancer

Heinzman, Z., Schmidt, C., Sliwinski, M. K., & Goonesekere, N. C. W. (2021) · Pharmaceuticals · doi:10.3390/ph14030209 · Cited by 3 · see citing works

Comparative effects of combustible cigarette versus electronic cigarette exposures on KRAS mutant lung cancer promotion

Velasco, W. V., Grimaldo, M. T., Karimi, N., Clowers, M. J., Krishna, A., Wu, R., Ejaz, R., Yuan, B., Aguila, S. W. D., Bouchelkia, I., et al. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101185 · Cited by 2 · see citing works

Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenocarcinoma

Yao, T.-H., Treekitkarnmongkol, W., Putluri, N., Sankaran, D., Nguyen, T., Balasenthil, S., Hurd, M. W., Chen, M., Brand, R. E., Lampe, P. D., et al. (2026) · Scientific Reports · doi:10.1038/s41598-025-29548-4 · Cited by 2 · see citing works

Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1

Ballarò, R., Wasylishen, A. R., Pieterman, C. R. C., Olsen, C., Irajizad, E., Wu, R., Katayama, H., Liu, H., Cai, Y., Léon-Letelier, R. A., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217537 · Cited by 1 · see citing works

Imaging Techniques and Biochemical Biomarkers: New Insights into Diagnosis of Pancreatic Cancer

Jafari, S. H., Lajevardi, Z. S., Fard, M. M. Z., Jafari, A., Naghavi, S., Ravaei, F., Taghavi, S. P., Mosadeghi, K., Zarepour, F., Mahjoubin‐Tehran, M., et al. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01437-z · Cited by 1 · see citing works

Circulating Cell-Free Mitochondrial DNA and Inflammation in Older Adults with Pancreatic Cancer: Results from an Exploratory Study

Girolimetti, G., Guerra, F., Eusebi, L. H., Ricci, C., Marzetti, E., Picca, A., & Bucci, C. (2025) · Applied Sciences · doi:10.3390/app15084410 · Cited by 1 · see citing works

Management of pancreatic ductal adenocarcinoma (PDAC): Progress in the past decade and challenges for the future

Clementine, R., Mas, L., Granier, S., Colle, E., Neuzillet, C., & Hammel, P. R. (2019) · Cancer Reports and Reviews · doi:10.15761/crr.1000184 · Cited by 1 · see citing works

Protein–metabolite panel for early-stage pancreatic cancer

Burki, T. K. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30651-x · Cited by 1 · see citing works

Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study

Zhao, R., Ren, S., Li, C., Guo, K., Lu, Z., Tian, L., He, J., Zhang, K., Cao, Y., Liu, S., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.5296 · Cited by 43 · see citing works

Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma

Cao, Y., Guo, K., Zhao, R., Li, Y., Lv, X.-J., Lu, Z., Tian, L., Ren, S., & Wang, Z. (2023) · Digital Health · doi:10.1177/20552076231179007 · Cited by 15 · see citing works

Plasma Metabolite Biomarkers for the Detection of Pancreatic Cancer

Xie, G., Lu, L., Qiu, Y., Ni, Q., Zhang, W., Gao, Y.-T., Risch, H. A., Yu, H., & Jia, W. P. (2014) · Journal of Proteome Research · doi:10.1021/pr501135f · Cited by 96 · see citing works

Metabolic biomarkers to differentiate pancreatic ductal adenocarcinoma and chronic pancreatitis

Mayerle, J. V., Kalthoff, H., Reszka, R. C., Kamlage, B., Peter, R. E., Schniewind, B., Maldonado, S. G., Liebenberg, V., Pilarsky, C. P., Schatz, P., et al. (2014) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0034-1386009